| Referências: |
Referências bibliográficas
-Laurence L Brunton, John S Lazo, Keith L Parker. GOODMAN & GILMAN (2011) As Bases Farmacológicas da Terapêutica. Ed Mcgraw-Hill. 12ª Edição.)
-Bertram G Katzung. Farmacologia Básica e Clínica 10a Edição, McGRAW-HILL LANGE– 2009.
-Arthur C. Guyton; John E. Hall. Guyton & Hall - Tratado de Fisiologia Médica.12° edição. Editora: Elsevier.
-Erick R Kandel, James H Schwartz, Thomas M Jessell. Princípios da neurociência. 4° edição Editora: Manole.
-Janet G Travel; David G Simons. Dor e disfunção miofascial. Editora: Artmed
-Latremoliere A, Woolf CJ. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. The journal of pain. 2009; 10: 895-926.
-Millan MJ. Descending control of pain. Progress in neurobiology. 2002; 66: 355-474.
Bibliografia complementar
- Margarida de Mello Aires (2008). Fisiologia. Editora Guanabara-Koogan (3ª Edição).
-Immke DC, Gavva NR. The TRPV1 receptor and nociception. Seminars in cell and developmental. 2006. 17: 582-591.
-Koppert W. Opioid-induced hyperalgesia – Pathophysiology and clinical relevance. Acute pain. 2007. 9: 21-34.
-Cury Y, Picolo G, Gutierrez VP, Ferreira SH. Pain and analgesia: The dual effect of nitric oxide in the nociceptive system. Nitric oxide. 2011; 25: 243-254.
-Svizenska I, Dubovy P, Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures – a short review. Pharmacology, biochemistry and behavior. 2008; 90: 501-511.
-Porter DG. Ethical scores for animal experiments. Nature. 1992. 356: 101-102.
|
